1 |
MAPK14
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
2 |
MAPK14
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
3 |
CSF2
| 4件: T cell receptor signaling pathway T cell receptor signaling pathway, TNF signaling pathway, Shigellosis, Transcriptional misregulation in cancer | D11343
D11343
|
Otilimab
| 1件: 46 46 |
4 |
EGFR
| 1件: Shigellosis Shigellosis | D01977
D01977
|
Gefitinib
| 1件: 75 75 |
5 |
EGFR
| 1件: Shigellosis Shigellosis | D03455
D03455
|
Cetuximab
| 2件: 51 51, 86 |
6 |
EGFR
| 1件: Shigellosis Shigellosis | D07907
D07907
|
Erlotinib
| 1件: 94 94 |
7 |
EGFR
| 1件: Shigellosis Shigellosis | D08108
D08108
|
Lapatinib
| 3件: 34 34, 74, 75 |
8 |
EGFR
| 1件: Shigellosis Shigellosis | D08950
D08950
|
Neratinib
| 1件: 34 34 |
9 |
EGFR
| 1件: Shigellosis Shigellosis | D11251
D11251
|
Icotinib
| 1件: 34 34 |
10 |
EGFR
| 1件: Shigellosis Shigellosis | D11772
D11772
|
Tesevatinib
| 1件: 67 67 |
11 |
MTOR
| 6件: Th17 cell differentiation Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis | D00753
D00753
|
Sirolimus
| 40件: 2 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331 |
12 |
MTOR
| 6件: Th17 cell differentiation Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis | D02714
D02714
|
Everolimus
| 9件: 34 34, 67, 89, 96, 137, 157, 158, 228, 277 |
13 |
MTOR
| 6件: Th17 cell differentiation Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis | D06068
D06068
|
Temsirolimus
| 1件: 13 13 |
14 |
IL1B
| 7件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Yersinia infection, Tuberculosis | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
15 |
IL1B
| 7件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Yersinia infection, Tuberculosis | D06635
D06635
|
Rilonacept
| 4件: 51 51, 106, 107, 266 |
16 |
IL1B
| 7件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Yersinia infection, Tuberculosis | D09315
D09315
|
Canakinumab
| 10件: 46 46, 56, 84, 106, 107, 108, 113, 266, 267, 269 |
17 |
IL1B
| 7件: Toll-like receptor signaling pathway Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Type I diabetes mellitus, Shigellosis, Yersinia infection, Tuberculosis | D09911
D09911
|
Gevokizumab
| 4件: 41 41, 50, 56, 269 |
18 |
IL1R1
| 2件: Th17 cell differentiation Th17 cell differentiation, Shigellosis | D02934
D02934
|
Anakinra
| 18件: 2 2, 13, 15, 28, 37, 41, 46, 49, 50, 56, 65, 84, 86, 97, 106, 107, 266, 299 |
19 |
NFKB1
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer | D01146
D01146
|
Iguratimod
| 5件: 46 46, 51, 53, 271, 300 |
20 |
PIK3CA
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11011
D11011
|
Alpelisib
| 1件: 138 138 |
21 |
PIK3CA
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
22 |
PIK3CB
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
23 |
PIK3CD
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11158
D11158
|
Leniolisib
| 2件: 53 53, 65 |
24 |
PIK3CD
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Shigellosis, Yersinia infection, Viral carcinogenesis, Small cell lung cancer | D11437
D11437
|
Parsaclisib
| 3件: 35 35, 53, 61 |
25 |
PRKCD
| 3件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Type II diabetes mellitus, Shigellosis | D09671
D09671
|
Sotrastaurin
| 1件: 97 97 |
26 |
PRKCE
| 5件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Tight junction, Type II diabetes mellitus, Shigellosis | D09671
D09671
|
Sotrastaurin
| 1件: 97 97 |
27 |
PRKCQ
| 5件: Vascular smooth muscle contraction Vascular smooth muscle contraction, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Shigellosis | D09671
D09671
|
Sotrastaurin
| 1件: 97 97 |
28 |
MAPK11
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
29 |
MAPK11
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
30 |
MAPK13
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
31 |
MAPK13
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
32 |
BCL2
| 5件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Shigellosis, Toxoplasmosis, Tuberculosis, Small cell lung cancer | D10679
D10679
|
Venetoclax
| 1件: 28 28 |
33 |
RELA
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Transcriptional misregulation in cancer, Viral carcinogenesis, Small cell lung cancer | D12181
D12181
|
Edasalonexent
| 1件: 113 113 |
34 |
ROCK1
| 6件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Tight junction, Shigellosis, Yersinia infection | D07941
D07941
|
Fasudil
| 4件: 2 2, 5, 7, 51 |
35 |
MAPK12
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D09639
D09639
|
Losmapimod
| 2件: 113 113, 222 |
36 |
MAPK12
| 13件: Sphingolipid signaling pathway Sphingolipid signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Thermogenesis, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis | D10959
D10959
|
Neflamapimod
| 1件: 8 8 |
37 |
SRC
| 7件: VEGF signaling pathway VEGF signaling pathway, Tight junction, Thyroid hormone signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis | D03252
D03252
|
Bosutinib
| 2件: 2 2, 67 |
38 |
SRC
| 7件: VEGF signaling pathway VEGF signaling pathway, Tight junction, Thyroid hormone signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis | D03658
D03658
|
Dasatinib
| 2件: 51 51, 85 |
39 |
SRC
| 7件: VEGF signaling pathway VEGF signaling pathway, Tight junction, Thyroid hormone signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis | D06414
D06414
|
Dasatinib
| 2件: 51 51, 85 |
40 |
SRC
| 7件: VEGF signaling pathway VEGF signaling pathway, Tight junction, Thyroid hormone signaling pathway, Shigellosis, Yersinia infection, Tuberculosis, Viral carcinogenesis | D09664
D09664
|
Saracatinib
| 3件: 6 6, 89, 272 |
41 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00742
D00742
|
Etanercept
| 16件: 15 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 107, 228, 270, 271, 285 |
42 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D00754
D00754
|
Thalidomide
| 20件: 2 2, 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 |
43 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D01583
D01583
|
Pirfenidone
| 11件: 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
44 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02597
D02597
|
Adalimumab
| 17件: 19 19, 37, 40, 41, 46, 56, 84, 96, 97, 107, 160, 164, 222, 226, 269, 270, 271 |
45 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D02598
D02598
|
Infliximab
| 27件: 35 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 85, 95, 96, 97, 98, 107, 162, 164, 269, 270, 271 |
46 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D03441
D03441
|
Certolizumab pegol
| 8件: 37 37, 46, 49, 96, 97, 107, 226, 271 |
47 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04358
D04358
|
Golimumab
| 8件: 46 46, 56, 84, 96, 97, 107, 270, 271 |
48 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D04687
D04687
|
Lenalidomide
| 8件: 16 16, 26, 28, 34, 49, 284, 300, 331 |
49 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D05393
D05393
|
Pegsunercept
| 1件: 46 46 |
50 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D08976
D08976
|
Pomalidomide
| 5件: 28 28, 51, 85, 227, 331 |
51 |
TNF
| 13件: Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, Sphingolipid signaling pathway, TGF-beta signaling pathway, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Type II diabetes mellitus, Type I diabetes mellitus, Shigellosis, Yersinia infection, Toxoplasmosis, Tuberculosis, Systemic lupus erythematosus | D09944
D09944
|
Ozoralizumab
| 1件: 46 46 |
52 |
C3
| 5件: Shigellosis Shigellosis, Staphylococcus aureus infection, Tuberculosis, Viral carcinogenesis, Systemic lupus erythematosus | D11613
D11613
|
Pegcetacoplan
| 4件: 2 2, 61, 62, 222 |
53 |
ROCK2
| 6件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Shigellosis, Yersinia infection | D07941
D07941
|
Fasudil
| 4件: 2 2, 5, 7, 51 |
54 |
ROCK2
| 6件: Sphingolipid signaling pathway Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Shigellosis, Yersinia infection | D11815
D11815
|
Belumosudil
| 2件: 51 51, 85 |